Cumberland Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $68.17 million, with shareholders equity totaling $17.11 million.
The company employs approximately 94 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Cumberland Pharmaceuticals Inc. reported $31.27 million in revenue, generating net income of $-10.92 million.
Key financial metrics include a P/E ratio of -6.24, a price-to-book (P/B) ratio of 3.98, and a trailing twelve-month dividend yield of 32.97%.
The company trades under the ticker CPIX.